Written question asked by Ian Lavery (Labour) on Friday, 30 August 2024, in the House of Commons. It was due for an answer on Tuesday, 3 September 2024. It was answered by Andrew Gwynne (Labour) on Thursday, 5 September 2024 on behalf of the Department of Health and Social Care.
Selective Serotonin Reuptake Inhibitors: Sexual Dysfunction
- Question
-
To ask the Secretary of State for Health and Social Care, what research his Department is undertaking on permanent antidepressant induced sexual dysfunction.
- Answer
-
The Department funds research through the National Institute for Health and Care Research (NIHR). The NIHR has funded previous studies focused on the effects of antidepressant medication on sexual function. For example, a systematic review to determine the effectiveness of management strategies for sexual dysfunction caused by antidepressants, and to determine the adverse effects and acceptability of these different management strategies. The NIHR is not currently funding any research with a focus on the permanency of antidepressant induced sexual dysfunction. The NIHR welcomes funding applications for research into any aspect of human health, including antidepressant-associated sexual dysfunction.
Secondary information
- Type
- Written question
- Reference
- 2901
- Session
- 2024-26
- Subjects
- Research Sexual dysfunction Selective serotonin reuptake inhibitors
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2025-09-05 21:02:15 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/2901
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/2901
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/2901